Diagnosis of von Willebrand disease Type 2N: A simplified method for measurement of factor VIII binding to von Willebrand factor

American Journal of Hematology

Volumn 58, Issue 4, 1998, Pages 311-318

  Miller, Connie H ^a,b   Kelley, Leslie ^a   Green, David ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Factor VIII; Von Willebrand disease; vWF mutations

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR 8; CYANOGEN BROMIDE; GLUTAMINE; POLYCLONAL ANTIBODY; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLEEDING TENDENCY; CASE REPORT; DIAGNOSTIC PROCEDURE; FAMILY STUDY; FEMALE; GENE MUTATION; HEMOPHILIA A; HUMAN; PRIORITY JOURNAL; VON WILLEBRAND DISEASE; X CHROMOSOMAL INHERITANCE;

ADULT; ANTIBODIES; BLOOD COAGULATION TESTS; CHILD; EXONS; FACTOR VIII; FEMALE; HEMOPHILIA A; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MUTATION; PEDIGREE; PREGNANCY; PROTEIN BINDING; SEPHAROSE; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0031817453     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199808)58:4<311::AID-AJH11>3.0.CO;2-A     Document Type: Article

References (33)

1. Ruggeri ZM, Ware J: The structure and function of von Willebrand factor. Thromb Haemost 67:594-599, 1992.
2. Sadler JE: A revised classification of von Willebrand disease. Thromb Haemost 71:520, 1994.
3. Mazurier C, Gaucher C, Jorieux S, Parquet-Gernez A, Goudemand M: Evidence for a von Willebrand factor defect in factor VIII binding in three members of a family previously misdiagnosed mild haemophilia A and haemophilia A carriers: Consequences for therapy and genetic counseling. Br J Haematol 76:372-379, 1990.
4. Tuley EA, Gaucher C, Jorieux S, Worrall NK, Sadler JE, Mazurier C: Expression of von Willebrand factor "Normandy:" An autosomal mutation that mimics hemophilia A. Proc Natl Acad Sci USA 88: 6377-6381, 1991.
5. Mazurier C: von Willebrand disease masquerading as haemophilia A. Thromb Haemost 67:391-396, 1992.
6. Schneppenheim R, Budde U, Krey S, Drewke E, Bergmann F, Lechler E, Oldenburg J, Schwaab R: Results of a screening for von Willebrand disease Type 2N in patients with suspected haemophilia A or von Willebrand disease Type 1. Thromb Haemost 76:598-602, 1996.
7. Nishino M, Girma JP, Rothschild C, Fressinaud E, Meyer D: New variant of von Willebrand disease with defective binding to factor VIII. Blood 74:1591-1599, 1989.
8. Mazurier C, Dieval J, Jorieux S, Delobel J, Goudemand M: A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction. Blood 75:20-26, 1990.
9. Cacheris PM, Nichols WC, Ginsburg D: Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor/factor VIII interaction. J Biol Chem 266:13499-13502, 1991.
10. Ginsburg D, Sadler JE: Von Willebrand disease: A database of point mutations, insertions, and deletions. Thromb Haemost 69:177-184, 1993.
11. Ginsburg D, Sadler JE: Von Willebrand factor database. University of Michigan (Ann Arbor, MI), 1997. Internet Web Site: http://mmg2.im. med.umich.edu/vWF/
12. Mazurier C, Meyer D: Factor VIII binding assay of von Willebrand factor and the diagnosis of Type 2N von Willebrand disease: Results of an international survey. Thromb Haemost 76:270-274, 1996.
13. Foster PA, Fulcher CA, Marti T, Titani K, Zimmerman TS: A major factor VIII binding domain resides within the amino terminal 272 amino acid residues of von Willebrand factor. J Biol Chem 262:8433-8436, 1987.
14. Takahashi Y, Kalafatis M, Girma JP, Serwin K, Andersson LO, Meyer D: Localization of a factor VIII binding domain on a 34 kDa fragment of the N-terminal portion of von Willebrand factor. Blood 70:1679-1682, 1987.
15. Meyer D, Fressinaud E, Gaucher C, Lavergne JM, Hilbert L, Ribba AS, Jorieux S, Mazurier C: Gene defects in 150 unrelated French cases with Type 2 von Willebrand disease: From the patient to the gene. Thromb Haemost 78:451-456, 1997.
16. Gaucher C, Mercier B, Jorieux S, Oufkir D, Mazurier C: Identification of two point mutations in the von Willebrand factor gene of three families with the "Normandy" variant of von Willebrand disease. Br J Haematol 78:506-514, 1991.
17. Lavergne JM, Piao Y, Ribba AS, Girma JP, Siguret V, Pietu G, Boyer-Neumann C, Schandelong A, Bahnak BR, Meyer D: Functional analysis of the Arg91Gln substitution in the factor VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression. Thromb Haemost 70:691-696, 1993.
18. Wise RJ, Ewenstein BM, Gorlin J, Narins SC, Jesson M, Handin RI: Autosomal recessive transmission of hemophilia A due to a von Willebrand factor mutation. Hum Genet 91:367-372, 1993.
19. Lopez-Fernandez MF, Blanco-Lopez MJ, Castineira MP, Batlle J: Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII. Am J Hematol 40:20-27, 1992.
20. Rick ME, Krizek DM: Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII. Am J Hematol 51:302-306, 1996.
21. 854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele. Br J Haematol 80:358-363, 1992.
22. Eikenboom JCJ, Reitsma PH, Peerlinck KM, Briet E: Recessive inheritance of von Willebrand's disease type I. Lancet 341:982-986, 1993.
23. Siguret V, Lavergne JM, Cheryl G, Boyer-Neumann C, Ribba AS, Bahnak BR, Meyer D, Pietu G: A novel case of compound heterozygosity with "Normandy"/type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD. Hum Genet 93: 95-102, 1994.
24. Kroner PA, Foster PA, Fahs SA, Montgomery RR: The defective interaction between von Willebrand factor and factor VIII in a patient with type I von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor. Blood 87:1013-1021, 1996.
25. Nesbitt IM, Goodeve AC, Guilliatt AM, Makris M, Preston FE, Peake IR: Characterisation of Type 2N von Willebrand disease using phenotypic and molecular techniques. Thromb Haemost 75:959-964, 1996.
26. Gu J, Jorieux S, Lavergne JM, Ruan C, Mazurier C, Meyer D: A patient with Type 2N von Willebrand disease is heterozygous for a new mutation: Gly22Glu. Demonstration of a defective expression of the second allele by the use of monoclonal antibodies. Blood 89:3263-3269, 1997.
27. Sadler JE, Ginsburg D: A database of polymorphisms in the von Willebrand factor gene and pseudogene. Thromb Haemost 69:185-191, 1993.
28. Peake I: Registry of DNA polymorphisms within or close to the human factor VIII and factor IX genes. Thromb Haemost 67:277-280, 1992.
29. Vlot AJ, Koppelman SJ, Meijers JCM, Damas C, van den Berg HM, Bouma BN, Sixma JJ, Willems GM: Kinetics of factor VIII-von Willebrand factor association. Blood 87:1809-1816, 1996.
30. Miller CH: Genetics of Hemophilia and von Willebrand's Disease. In: Hilgartner MW, Pochedly C (eds): Hemophilia in the Child and Adult. New York: Raven Press, 1989, pp 297-345.
31. Lakich D, Kazazian HH, Antonarakis SE, Gitschier J: Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nature Genet 5:236-241, 1993.
32. Miller CH, Hilgartner MW, Harris MB, Bussel JB, Aledort LM: Concurrence of von Willebrand's disease and hemophilia A: Implications for carrier detection and prevalence. Am J Med Genet 24:83-94, 1986.
33. Weiss HJ, Ball AP, Mannucci PM: Incidence of severe von Willebrand's disease. N Engl J Med 307:127, 1982.